Your dynamic consulting firm
PharmaPlus Consultancy is a strategic consulting and biopharmaceutical business development company. We work with biotech and pharmaceutical companies and non-profit research organizations. We focus on products and technologies with strong innovation and intellectual property.
We facilitate early stage (preclinical-clinical phase II) licensing deals based on strategic technology analysis and consulting, business development and deal negotiation. We uniquely combine our full consultancy services with technology scouting, university licensing deal reports and two distinctive online licensing databases.
Our approach balances new and innovative as well as traditional solutions to your key objectives. We offer our services on a worldwide basis and work with an international network of partners. We are totally committed and work based on a review of your needs, goals and challenges.
- Technology screening
- Licensing opportunity identification
- Patent portfolio analysis
- In-licensing & out-licensing
- Partnering strategy
- Non-confidential teasers
- Partner identification
- Licensing negotiations
- Unpublished Pharma Patent Applications database - online early stage partnering database
- Biotechgate Licensing Deals database - online therapeutic licensing deal financials database
- University licensing deals database extracts
Our experience covers a wide range of indications, including autoimmune disorders, blood & blood forming organs, bone disorders, cardiovascular disorders, CNS disorders, dermatology, eye disorders, genetic disorders, infectious diseases, musculoskeletal disorders, oncology, respiratory disorders and transplantation.
Given the nature of our work, our client activities are strictly confidential.
Karin Bakker is founder and principal of PharmaPlus Consultancy and has spent her entire 20+ year career in the life science sector. She provides a unique perspective that bridges industry and academia, business and science.
Since 1996 Karin has consulted for a large variety of organizations with an interest in the life science sector. She has facilitated both a M&A deal and a number of regional & global licensing deals and has an extensive network in the global biopharmaceutical industry.
Previously Karin co-founded consultancy company Bakker & Pronk, delivering project management, disease management, reimbursement services and market studies for the Dutch market to clients like ALK-Abelló, Alliance Boots, Merck Organon (Merck & Co) and Sanofi.
Karin worked at NPBI (Fresenius), where she was responsible for international business development and project management and facilitated the company’s first licensing deal for the US market. She has a degree in pharmacy.